This study investigates a strategy of low-pressure stenting with concomitan
t anti-platelet treatment designed to prevent short- and long-term events a
fter stenting. Ninety consecutive patients who underwent percutaneous trans
luminal coronary angioplasty with stenting using low-pressure stent deploym
ent (mean 8.1 atmospheres) with concomitant anti-platelet therapy based on
ticlopidine and aspirin were followed. The 30-day outcome revealed a stent
thrombosis rate of 6.4%, while the 9-month major clinical event rate was 8.
6%. Low-pressure stent deployment appears to confer added risk for acute or
sub-acute thrombosis even when aspirin and ticlopidine are used. Conversel
y, low-pressure inflation is associated with excellent long-term results. C
oron Artery Dis 12:313-316 (C) 2001 Lippincott Williams & Wilkins.